Methods | ||
Participants | ||
Interventions | ||
Outcomes | ||
Treatment type | ||
Notes | Treated as an included study in order to contribute to adverse event meta‐analyses; Excluded for efficacy: 431 smokeless tobacco users in Norway and Sweden, randomised to varenicline or placebo; CAR assessed at 12 and 26 weeks. |